
- /
- Supported exchanges
- / US
- / BIAF.NASDAQ
bioAffinity Technologies, Inc. (BIAF NASDAQ) stock market data APIs
bioAffinity Technologies, Inc. Financial Data Overview
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with bioAffinity Technologies, Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get bioAffinity Technologies, Inc. data using free add-ons & libraries
Get bioAffinity Technologies, Inc. Fundamental Data
bioAffinity Technologies, Inc. Fundamental data includes:
- Net Revenue: 7 681 K
- EBITDA: -9 490 369
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-14
- EPS/Forecast: -0.1
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
bioAffinity Technologies, Inc. News

bioAffinity Technologies announces 1-for-30 reverse stock split to regain Nasdaq compliance; shares down ~22%
* bioAffinity Technologies (NASDAQ:BIAF [https://seekingalpha.com/symbol/BIAF]) will implement a 1-for-30 reverse stock split effective at market open on September 19, 2025. * The reverse split re...


Tuesday's session: top gainers and losers
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT GORV [https://www.chartmill.com/...

These stocks have an unusual volume in today's session
Volume analysis on 2025-09-16: stocks with an unusual volume in today's session. [unusualvolume] TOP UNUSUAL VOLUME STOCKS TICKER CHANGE COMMENT MTVA [https://www.chartmill.com/stock/quo...

Let's take a look at the stocks that are in motion in today's session.
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. [topmovers] TOP GAINERS TICKER CHANGE COMMENT FGI [https://www.chartmill...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.